ACHE and Alzheimer disease: The majority of FDA-approved drugs for AD (e.g., tacrine, donepezil, rivastigmine, galantamine) act by countering the cholinergic deficit associated with cognitive dysfunction and are based on the inhibition of the enzyme acetylcholinesterase (AChE) [5,6].